Hostname: page-component-89b8bd64d-shngb Total loading time: 0 Render date: 2026-05-11T05:46:34.036Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of respiratory virus infection in patients with chronic chest disease

Published online by Cambridge University Press:  15 May 2009

M. J. Wiselka ,
J. Kent ,
J. B. Cookson  and
K. G. Nicholson
M. J. Wiselka*
Affiliation:
Department of Infectious Diseases, Leicester Royal Infirmary, Leicester LE1 5WW
J. Kent
Affiliation:
Department of Infectious Diseases, Leicester Royal Infirmary, Leicester LE1 5WW
J. B. Cookson
Affiliation:
Department of Respiratory Medicine, Glenfield General Hospital, Leicester LE3 9QQ, UK
K. G. Nicholson
Affiliation:
Department of Infectious Diseases, Leicester Royal Infirmary, Leicester LE1 5WW
*
*Dr M. J. Wiselka, Infections Diseases Unit, Ward 38, Leicester Royal Infirmary, Leicester LE1 5WW.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

This study investigated the morbidity associated with respiratory virus infections in patients with well-documented chest disease, and the risk of transmission between close contacts. Patients informed the study team if they were exposed to a family member or colleague with a cold. Patients and symptomatic index cases recorded respiratory symptoms during the study period. Acute nasopharyngeal swabs and paired sera were obtained for viral diagnosis.

Twenty-five (43%) of 58 recorded exposures resulted in a symptomatic illness and 16 (28%) patients developed lower respiratory tract symptoms. Sixteen (64%) of the 25 symptomatic patients contacted their general practitioner, 14 (56%) received antibiotics and 4 (16%) were hospitalized. Mean duration of illness was 10·6 days in symptomatic patients and 5·7 days in their corresponding index cases (P < 0·005). Mean symptom scores were 100·6 in symptomatic patients and 62.2 in index cases (P < 0·01). Respiratory viruses were identified in 19 (33%) episodes. Rhinovirus, coronavirus and respiratory syncytial virus infections were all associated with lower respiratory tract exacerbations.

Respiratory tract symptoms following exposure to a cold were comparatively severe in these patients with chronic chest disease. This group of patients might gain particular benefit from the introduction of effective vaccines or antiviral therapy.

Information

Type
Research Article
Information
Epidemiology & Infection , Volume 111 , Issue 2 , October 1993 , pp. 337 - 346
Copyright
Copyright © Cambridge University Press 1993

References

REFERENCES

1.Stuart-Harris, CH. The role of bacterial and viral infection in chronic bronchitis. Arch Environ Health 1968; 16: 586–95.CrossRefGoogle ScholarPubMed
2.Stott, EJ, Grist, NR, Eadie, MB. Rhinovirus infections in chronic bronchitis: isolation of eight possibly new rhinovirus serotypes. J Med Micro 1968; 1: 109–17.CrossRefGoogle Scholar
3.Monto, AS, Higgins, MW, Ross, HW. The Tecumseh study of respiratory illness. VIII. Acute infection in chronic respiratory disease and comparsion groups. Am Rev Infect Dis 1975; 111: 27–36.Google Scholar
4.Buscho, RO, Saxton, D, Shultz, PS, Finch, E, Mufson, MA. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 1978; 137: 377–83.CrossRefGoogle ScholarPubMed
5.Horn, MEC, Gregg, I. Role of viral infection and host factors in acute episodes of asthma and chronic bronchitis. Chest 1973; 63: 44S–48S.CrossRefGoogle ScholarPubMed
6.Minor, TE, Dick, EC, DeMeo, AN et al. Viruses as precipitants of asthmatic attacks in children. JAMA 1974; 227: 292–8.CrossRefGoogle ScholarPubMed
7.Minor, TE, Dick, EC, Baker, JW et al. Rhinovirus and Influenza type A infections as precipitants of asthma. Am Rev Resp Dis 1976; 113: 149–53.Google ScholarPubMed
8.Mitchell, I, Inglis, H, Simpson, H. Viral infection in wheezy bronchitis and asthma in children. Arch Dis Child 1976; 51: 707–11.CrossRefGoogle Scholar
9.Carlsen, KH, Orstavic, I, Leegaard, J, Hoeg, H. Respiratory virus infection and aeroallergens in acute bronchial asthma. Arch Dis Child 1984; 59: 310–15.CrossRefGoogle ScholarPubMed
10.Busse, WW. The precipitation of asthma by upper respiratory tract infections. Chest 1985; 87: 44S–49S.CrossRefGoogle Scholar
11.Tarlo, S, Broder, I, Spence, L. A prospective study of respiratory infection in adult asthmatics and their spouses. Clin Allergy 1979; 9: 293–301.CrossRefGoogle ScholarPubMed
12.Wang, EEL, Prober, CG, Manson, B, Corey, M, Levison, H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 1984; 311: 1653–8.CrossRefGoogle ScholarPubMed
13.Department of Health, Welsh Office, Scottish Home and Health Department. Influenza. In: Immunisation against infections diseases. London: HMSO, 1992: 95–9.Google Scholar
14.Wiselka, MJ, Nicholson, KG, Kent, J, Cookson, JB, Tyrrell, DAJ. Prophylactic intransal alpha2-interferon and viral exacerbations of chronic respiratory disease. Thorax 1991; 46: 706–11.CrossRefGoogle Scholar
15.Phillpotts, RJ. Clones of MRC-C cells may be superior to the parent line for the culture of 229E-like strains of human respiratory coronavirus. J Virol Methods 1983; 6: 267–9.CrossRefGoogle Scholar
16.Kraaijeveld, CA, Reed, SE, Macnaughton, MR. Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229E. J Clin Microbiol 1980; 12: 493–7.CrossRefGoogle Scholar
17.Monto, AS, Bryan, ER, Ohmit, S. Rhinovirus infections in Tecumseh, Michigan: Frequency of illness and number of serotypes. J Infect Dis 1987; 156: 43–9.CrossRefGoogle ScholarPubMed
18.Cate, TR, Couch, RB, Fleet, WF, Griffith, WR, Gerone, PJ, Knight, V. Production of tracheobronchitis in volunteers with rhinovirus in a small-particle aerosol. Am J Epidermal 1964; 81: 95–105.CrossRefGoogle Scholar
19.Halperin, SA, Eggleston, PA, Beasley, P et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985; 132: 976–80.Google ScholarPubMed
20.Busse, WW. The relationship between viral infections and onset of allergic diseases and asthma. Clin Exp Allergy 1989; 19: 1–9.CrossRefGoogle ScholarPubMed
21.Farr, BM, Gwaltney, JM Jnr, Adams, KF, Hayden, FG. Intranasal interferon alpha 2 for prevention of natural rhinovirus colds. Antimicrob Agents Chemother 1984; 26: 31–4.CrossRefGoogle ScholarPubMed
22.Monto, AS, Shope, TC, Schwartz, SA, Albrecht, JK. Intranasal interferon alpha-2b for seasonal prophylaxis of respiratory infection. J Infect Dis 1986; 154: 128–33.CrossRefGoogle ScholarPubMed
23.Douglas, RM, Moore, BW, Miles, HB, et al. Prophylactic efficacy of prophylactic alpha2-interferon in the family setting. N Engl J Med 1986; 314: 65–70.CrossRefGoogle Scholar
24.Hayden, FG, Albrecht, JK, Kaiser, DL, Gwaltney, JM Jr. Prevention of natural colds by contact prophylaxis with intranasal alpha2-interferon. N Engl J Med 1986; 314: 71–5.CrossRefGoogle Scholar
25.Monto, AS, Albrecht, JK, Schwartz, SA. Demonstration of dose–response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon. Antimicrob Agents Chemother 1988; 32: 47–50.CrossRefGoogle ScholarPubMed
26.Ireland, DC, Kent, J, Nicholson, KG. Improved detection of rhinovirus in nasal and throat swabs by semi-nested RT-PCR. J Med Virol 1993; 40: 96–101.CrossRefGoogle Scholar